Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02968238 · ClinicalTrials.gov registry record · NA

Tranquil Moments II-CBT vs. Yoga for Worry

A NA study of Anxiety, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT02968238: Completed NA study of Anxiety, sponsored by Wake Forest University Health Sciences.

NCT02968238 is a NA study of Anxiety that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 500 participants, above the 439-participant average among 364 other Anxiety trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02968238, a NA study of Anxiety, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

Anxiety disorders are the most prevalent psychiatric disorders. Among older adults, anxiety is more common that depression, yet research on the nature and treatment of anxiety has lagged far behind that of depression. The investigators' work has demonstrated that CBT is superior to enhanced usual care as well as supportive therapy in improving worry, depressive symptoms, and sleep, and these improvements are maintained for up to 1 year upon completing treatment. Research demonstrates that yoga reduces anxiety symptoms and the investigators' own work demonstrates that yoga improves sleep. However, no one has conducted a comparative effectiveness trial of CBT and yoga for treating worry in older adults. In fact, there are very few comparative effectiveness trials for treating late-life anxiety. Thus, clinicians are unable to provide an informed recommendation of one treatment over the other. The investigators propose a two-stage randomized preference trial comparing 1) cognitive-behavioral therapy with 2) yoga for the treatment of worry in a sample of older adults. Participants will be randomized to either the preference group (participants choose the treatment) or to the random group (participants are randomized to 1 of the 2 treatments). This study design allows for the calculation of traditional treatment effects (differences in outcomes between participants randomized to either CBT or yoga), selection effects (differences in outcomes between participants who choose CBT and those who choose yoga), and preference effects (differences in outcomes between participants who choose their treatment and those who are randomized to treatment).

Primary Outcome

worry symptoms

Conditions Studied

Interventions

  • BEHAVIORAL Yoga
  • BEHAVIORAL Cognitive-behavioral therapy

Study Locations (1)

North Carolina

  • Wake Forest University Health Sciences - Winston-Salem

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2017-05-01
Est. Completion 2019-08-28
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT02968238 record still lists

NCT02968238 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 439-participant average among 364 other Anxiety trials with a reported enrollment target (14% higher).

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Yoga is the first listed.

NCT02968238 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02968238 about?

NCT02968238 is a clinical study titled "Tranquil Moments II-CBT vs. Yoga for Worry". Anxiety disorders are the most prevalent psychiatric disorders. Among older adults, anxiety is more common that depression, yet research on the nature and treatment of anxiety has lagged far behind that of depression. The investigators' work has demonstrated that CBT is superior to enhanced usual ca...

What is the current status of trial NCT02968238?

This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2017-05-01. Estimated completion is 2019-08-28.

What conditions does trial NCT02968238 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT02968238?

The interventions under investigation include: Yoga (BEHAVIORAL), Cognitive-behavioral therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02968238?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02968238 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02968238's enrollment target sits among peer trials

500 31st of 364 higher than 329 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02968238, the US trial registry maintained by the National Library of Medicine. NCT02968238 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.